BIIB
Biogen Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#445 today
$219.88
-1.32% today · -3.39% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- BIIB −1.32% on the last session vs SPY +0.74%: −2.1 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
BIIB against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #445 | -1.32% | +0.74% | |
| 1 week | #408 | -3.39% | -0.22% | |
| 1 month | #141 | -1.25% | +0.84% | |
| 3 months | #162 | +1.74% | +3.59% | |
| 6 months | #97 | +23.99% | +17.95% | |
| 1 year | #74 | +41.63% | +16.25% | |
| Overall | #191 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Drug Manufacturers - General
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.09 | #413 | #6 |
| fPE/tPE | 0.34 | #36 | #4 |
| PE/G | 2.27 | #382 | #4 |
| EV/Revenue | 3.94 | #236 | #7 |
| Gross Margin | 0.78 | #48 | #3 |
| Profit Margin | 0.08 | #355 | #6 |
| Revenue Growth | 0.03 | #394 | #8 |